MINOCA presenting with STEMI: incidence, aetiology and outcome in a contemporaneous cohort Ying X. GueNatasha CorballisDiana A. Gorog OriginalPaper 20 July 2019 Pages: 533 - 538
Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018 Nayyra FataniChristopher FanikosJohn Fanikos Report 03 August 2019 Pages: 539 - 541
Assessment of the reporting quality of RCTs for novel oral anticoagulants in venous thromboembolic disease based on the CONSORT statement Ioannis LiampasAntonios ChlinosEfthimios Dardiotis ReviewPaper 10 August 2019 Pages: 542 - 553
Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid–aspirin complex: results of a randomized, crossover, bioequivalence study Dominick J. AngiolilloDeepak L. BhattUpendra Marathi OriginalPaper Open access 16 August 2019 Pages: 554 - 562
Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial Axel ÅkerblomDaniel Wojdylathe PLATO Investigators OriginalPaper Open access 11 September 2019 Pages: 563 - 569
Assessment of warfarin algorithms for hospitalized adults: searching for a safe dosing strategy Jessica L. CohenElena ThompsonJason J. Wang OriginalPaper 21 June 2019 Pages: 570 - 579
Interhospital transfer on intravenous thrombolysis in patients with acute ischemic stroke in three chinese municipal stroke centers Yunlong DingZhanyi JiYan Liu OriginalPaper 01 July 2019 Pages: 580 - 586
Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the COMMAND VTE registry Yuji NishimotoYugo Yamashitathe COMMAND VTE Registry Investigators OriginalPaper 05 July 2019 Pages: 587 - 595
Assessing patient preferences for switching from warfarin to direct oral anticoagulants Jack N. WrightSara R. VazquezDaniel M. Witt OriginalPaper 04 July 2019 Pages: 596 - 602
Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study Maciej Wiktor PolakJakub SiudutAnetta Undas OriginalPaper Open access 20 August 2019 Pages: 603 - 609
Pre-procedural abnormal function of von Willebrand Factor is predictive of bleeding after surgical but not transcatheter aortic valve replacement Kajetan GrodeckiKarol ZbrońskiZenon Huczek OriginalPaper Open access 29 July 2019 Pages: 610 - 618
Apixaban: a novel agent to treat heparin induced thrombocytopenia and to prevent embolism in patient with atrial fibrillation after multiple valve replacement? Matej SamošTomáš BolekMarián Mokán Report 01 July 2019 Pages: 619 - 622
Description of anti-Xa monitoring practices during low molecular weight heparin use Albert LinSara R. VazquezDaniel M. Witt OriginalPaper 17 July 2019 Pages: 623 - 628
Survey of confidence in use of stroke and bleeding risk calculators, knowledge of anticoagulants, and comfort with prescription of anticoagulation in challenging scenarios: SUPPORT-AF II study Azraa AmrozeKathleen MazorAlok Kapoor OriginalPaper 11 September 2019 Pages: 629 - 637
A narrative review of red blood cell distribution width as a marker for pulmonary embolism Lindsay HammonsJason FilopeiEric Bondarsky ReviewPaper 21 June 2019 Pages: 638 - 647
Assessment of preoperative hypercoagulability in patients with pancreatic ductal adenocarcinoma (PDAC) using rapid thromboelastography (r-TEG) Yu MouMao LiBole Tian OriginalPaper 27 June 2019 Pages: 648 - 652
Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings Takanori IkedaSatoshi OgawaSatoshi Yamanaka OriginalPaper Open access 20 August 2019 Pages: 653 - 660
Ticagrelor after pharmacological thrombolysis in patients with ST-segment elevation myocardial infarctions: insight from a trial sequential analysis Mohammed OsmanBabikir KheiriJason A. Moreland BriefCommunication 10 September 2019 Pages: 661 - 667
Venous thromboembolism 2011–2018 in Stockholm: a demographic study Per WändellTomas ForslundMargareta Holmström OriginalPaper Open access 01 October 2019 Pages: 668 - 673
Next generation sequencing in bleeding disorders: two novel variants in the F5 gene (Valencia-1 and Valencia-2) associated with mild factor V deficiency A. MoretÁngel ZúñigaS. Bonanad BriefCommunication 02 July 2019 Pages: 674 - 678
Intravenous thrombolysis in acute ischemic stroke due to intracranial artery dissection: a single-center case series and a review of literature Francisco BernardoStefania NannoniGaia Sirimarco BriefCommunication 13 July 2019 Pages: 679 - 684
The need for an adapted initiation nomogram during Fiix prothrombin time monitoring of warfarin Pall T. OnundarsonBrynja R. Gudmundsdottir BriefCommunication 10 August 2019 Pages: 685 - 689
First evidence for a pharmacist-led anticoagulant clinic in a medicare part A long term care environment Jeffrey A. GrayRalph A. LugoDavid W. Stewart Report 26 September 2019 Pages: 690 - 693
Ibrutinib related bleeding complications in elderly patients with B cell malignancies Roberto CastelliRiccardo SchiavonGiorgio Lambertenghi Deliliers Letter to the Editor 25 June 2019 Pages: 694 - 696
Lethal concentrations of mercury or lead do not affect coagulation kinetics in human plasma Vance G. Nielsen Letter to the Editor 17 July 2019 Pages: 697 - 698